Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds

Journal of Medicinal Chemistry

Volumn 39, Issue 7, 1996, Pages 1447-1451

  Kuo, Sheng Chu ^a   Ibuka, Toshiro ^b   Huang, Li Jiau ^a   Lien, Jin Cherng ^a   Yean, Shyue Ren ^a   Huang, Shung Chieh ^a   Lednicer, Daniel ^c   Morris Natsehke, Susan ^b   Lee, Kuo Hsiung ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 2 METHYLNAPHTH[2,3 D]IMIDAZOLE 4,9 DIONE; 3 CHLORO 2 [(2 FLUOROPHENYL)ACETAMIDO] 1,4 NAPHTHOQUINONE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; DRUG CONFORMATION; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; NAPHTHOQUINONES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0029940897     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950247k     Document Type: Article

References (18)

1. Morton, R. A., Ed. Biochemistry of Quinones; Academic Press: New York, 1965.
2. Hoffmann-Ostenhof, O. Enzyme Inhibition by Quinones. Metab. Inhib. 1963, 2, 145-159.
3. Hoover, J. R. E.; Day, A. R. Preparation of Some Imidazole Derivatives of 1,4-Naphthoquinone. J. Am. Chem. Soc. 1954, 76, 4148-52.
4. Oesterreichesehe, Stichkstoffwerk, A. G. Belg 610, 311, May 14, 1962; Appl. Nov 14, 1961, 6 pp.
5. Lin, A. J.; Cosby, L. P.; Sartorelli, A. C. Quinones as Anticancer Agents: Potential Bioreductive Alkylating Agents. Cancer Chemother. Rep. Part 2 1974, 4, 23-26.
6. Driscoll, J. S.; Hazard, G. F., Jr.; Wood, H. B., Jr.; Golden, A. Structure-Antitumor Activity Relationships Among Quinone Derivatives. Cancer Chemother. Rep. Part 2 1974, 4, 1-27.
7. Kuznetsov, V. S.; Efros, L. S. Heterocyclic Derivatives Based on Substituted 1,4-Naphoquinones. Zh. Org. Khim. 1965, 1, 1458-1465.
8. Efimove, G. A.; Efros, L. S. Heterocyclic Derivatives of Substituted 1,4-Naphthoquinones IV. Zh. Org. Khim. 1967, 3, 162-168.
9. Stetsenko, N. M.; Sirenko, L. A.; Stetsenko, A. V.; Arendarchuk, V. V. Algicidal Action of Condensed Imidazole Derivatives. "Tsvetenic" Vody. 1969, 2, 186-197.
10. Pickering, M. V.; Dea, P.; Streeter, D. G.; Witkowski, J. T. Synthesis and Biochemical Evaluation of Nucleosides of Naphthoquinone Heterocycles. J. Med. Chem. 1977, 20, 818-821.
11. Hayashi, T.; Smith, F. T.; Lee, K. H. Antitumor Agents 89. Psychorubrin, a New Cytotoxic Naphthoquinone from Psychotria rubra and Its Structure-Activity Relationships. J. Med. Chem. 1987, 26, 2005-2008.
12. Li, L.; Wang, H. K; Kuo, S. C.; Wu, T. S.; Lednicer, D.; Lin, C. M.; Hamel, E.; Lee, K. H. Antitumor Agents. 150. 2′,3′,4′,5′,5,6,7-Substituted 2-Phenyl-4-quinolones and Related Compounds: Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization. J. Med. Chem. 1994, 37, 1126-1135.
13. Dorofeenko, G. N.; Zhdanov, Y. A. C-Substituted Carbohydrates with Heterocyclic Aglucones II. Reaction of 1,2-Naphthylenediamine with Aldonic Acids. Zh. Obshck. Khim. 1960, 30, 3451-3455.
14. Stetsenko, A. V.; Lishko, V. K. Imidocyanines Containing Electronegative Substituents. Ukr. Khim. Zh. 1962, 28, 218-222.
15. Stetsenko, A. V.; Kul'chitskü, M. M. Imidocyanines from Derivatives of 2-Methylnaphth[2,3-d]imidazole-4,9-dione. Ukr. Khim. Zh. 1969, 35, 288-291.
16. Truitt, P.; Hayes, D.; Creagh, L. T. 1.2-Disubstituted Naphth-[2,3-d]imidazole-4,9-diones and Corresponding Quarternary Salts. J. Med. Chem. 1964, 7, 362-364.
17. Boyd, M. R. Status of the NCI Preclinical Antitumor Drug Discovery Screen. In Cancer: Principles and Practice of Oncology Updates; De Vita, V. T., Hellman, S., Rosenberg, S. A., Eds.; J. B. Lippincott: Philadelphia, 1989; pp 1-12.
18. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a High-flux Anticancer Drug Screen Utilizing a Derived Panel of Human Tumor Cell Lines in Culture. J. Natl. Cancer Inst. 1991, 83, 757-766.